The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding Replimune Group’s Biologics License Application…
Read More

The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding Replimune Group’s Biologics License Application…
Read More
The profound loss of appetite that accompanies severe gastrointestinal distress is a universal human experience, yet the precise biological mechanisms…
Read More
The loss of the sense of smell, or anosmia, has long been documented as one of the most frequent and…
Read More
A groundbreaking discovery by researchers at the University of Helsinki is poised to revolutionize our understanding of plant cellular dynamics,…
Read More
The phenomenon is a familiar one: the sudden and profound loss of appetite that accompanies a severe gastrointestinal illness. While…
Read More